Connect
MJA
MJA

Progressive multifocal leukoencephalopathy: a complication of prolonged immunosuppression for plasma cell myeloma

Sophie C Burn and Akash Kalro
Med J Aust 2021; 215 (10): . || doi: 10.5694/mja2.51315
Published online: 15 November 2021

A 66‐year‐old man presented to a tertiary emergency department following a fall. He had a 6‐month history of agitation, personality change, progressive cognitive impairment, dysarthria, dysphagia and recurrent falls. On examination, there was proximal muscle wasting and weakness, brisk reflexes and an upgoing plantar reflex on the left foot. Cranial nerve examination was normal.


  • Central Adelaide Local Health Network, Adelaide, SA


Correspondence: sophie.burn@sa.gov.au

Competing interests:

No relevant disclosures.

  • 1. Berger JR, Aksamit AJ, Clifford DB, et al. PML diagnostic criteria: consensus statement from the AAN neuroinfectious disease section. Neurology 2013; 80: 1430–1438.
  • 2. Pavlovic D, Patera AC, Nyberg F, et al. Progressive multifocal leukoencephalopathy: current treatment options and future perspectives. Therap Adv Neurol Disord 2015; 8: 255–273.
  • 3. Bennett KM, Storrar N, Johnson P, Fernandes PM. Progressive multifocal leukoencephalopathy (PML) following autologous peripheral blood stem cell transplantation for multiple myeloma. Clin Case Rep 2020; 8: 938–943.
  • 4. Akiyama M, Takahashi T, Nomura S, et al. Progressive multifocal leukoencephalopathy in patient with multiple myeloma. Int J Hematol 2010; 92: 186.
  • 5. Cortese, I, Muranski P, Enose‐Akahata Y, et al. Pembrolizumab treatment for progressive multifocal leukoencephalopathy. N Engl J Med 2019; 380: 1597–1605.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.